DK0881908T3 - Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst - Google Patents
Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækstInfo
- Publication number
- DK0881908T3 DK0881908T3 DK95914690T DK95914690T DK0881908T3 DK 0881908 T3 DK0881908 T3 DK 0881908T3 DK 95914690 T DK95914690 T DK 95914690T DK 95914690 T DK95914690 T DK 95914690T DK 0881908 T3 DK0881908 T3 DK 0881908T3
- Authority
- DK
- Denmark
- Prior art keywords
- growth
- treatment
- stimulate bone
- bone
- fiber blast
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
- C07K14/501—Fibroblast growth factors [FGF] acidic FGF [aFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/85—Investigating moving fluids or granular solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/10—Starch-containing substances, e.g. dough
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20798594A | 1994-03-08 | 1994-03-08 | |
PCT/US1995/002847 WO1995024211A1 (en) | 1994-03-08 | 1995-03-06 | Use of fibroblast growth factors to stimulate bone growth |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0881908T3 true DK0881908T3 (da) | 2004-10-25 |
Family
ID=22772771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95914690T DK0881908T3 (da) | 1994-03-08 | 1995-03-06 | Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst |
Country Status (11)
Country | Link |
---|---|
US (1) | US5614496A (da) |
EP (1) | EP0881908B1 (da) |
JP (1) | JPH09510209A (da) |
AT (1) | ATE269102T1 (da) |
AU (1) | AU685619B2 (da) |
CA (1) | CA2184916C (da) |
DE (1) | DE69533176T2 (da) |
DK (1) | DK0881908T3 (da) |
ES (1) | ES2225840T3 (da) |
PT (1) | PT881908E (da) |
WO (1) | WO1995024211A1 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE203913T1 (de) * | 1993-05-31 | 2001-08-15 | Kaken Pharma Co Ltd | Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält |
US5656598A (en) * | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
EP0800530A4 (en) * | 1994-07-20 | 1998-12-02 | Celtrix Pharma | IGF / IGFBP COMPLEX FOR PROMOTING BONE TRAINING AND REGULATING BONE REMODELING |
US6008208A (en) | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
US6221854B1 (en) * | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
US6649631B1 (en) | 1997-10-23 | 2003-11-18 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating bone deficit conditions |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
US6313103B1 (en) | 1998-05-13 | 2001-11-06 | Carrington Laboratories, Inc. | Pectic substance as a growth factor stabilizer |
US7022683B1 (en) * | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
US6838436B1 (en) | 1998-07-10 | 2005-01-04 | Osteoscreen Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
US6462019B1 (en) | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
US6902721B1 (en) | 1998-07-10 | 2005-06-07 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
DK1112095T3 (da) | 1998-09-11 | 2003-03-17 | Michael Dr Raschke | Biologisk aktive implantater |
US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
IL149562A0 (en) | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
EP1613267A2 (en) * | 2003-03-27 | 2006-01-11 | Children's Hospital Medical Center | Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US20050244451A1 (en) * | 2004-05-03 | 2005-11-03 | Robert Diaz | Method and device for reducing susceptibility to fractures in vertebral bodies |
US20050244499A1 (en) * | 2004-05-03 | 2005-11-03 | Robert Diaz | Method and device for reducing susceptibility to fractures in long bones |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US20060089642A1 (en) * | 2004-10-27 | 2006-04-27 | Diaz Robert L | Prefracture spinal implant for osteoporotic unfractured bone |
US7815926B2 (en) * | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
JP2009508596A (ja) | 2005-09-19 | 2009-03-05 | ヒストジェニックス コーポレイション | 細胞支持基材及びその調製方法 |
US8298528B2 (en) * | 2006-04-17 | 2012-10-30 | Hepacore Ltd. | Methods for bone regeneration using endothelial progenitor cell preparations |
JP5815206B2 (ja) * | 2006-08-25 | 2015-11-17 | アレス トレーディング ソシエテ アノニム | Fgf−18を用いた軟骨障害の治療 |
EP2083846B1 (en) | 2006-09-28 | 2015-07-15 | Hepacore Ltd. | N-terminal fgf variants having increased receptor selectivity and uses thereof |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
WO2009111069A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL68218A (en) * | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
US4868113A (en) * | 1986-03-03 | 1989-09-19 | Rorer Biotechnology, Inc. | Recombinant DNA vector encoding human endothelial cell growth factor |
US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5077049A (en) * | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
AU629316B2 (en) * | 1990-04-11 | 1992-10-01 | Flora Inc. | Periodontal disease treatment system |
ATE139700T1 (de) * | 1991-02-15 | 1996-07-15 | Takeda Chemical Industries Ltd | Mit einem zellwachstumsfaktor bewirkte anregung von wachstum im knocheninneren |
-
1995
- 1995-03-06 DE DE69533176T patent/DE69533176T2/de not_active Expired - Lifetime
- 1995-03-06 DK DK95914690T patent/DK0881908T3/da active
- 1995-03-06 ES ES95914690T patent/ES2225840T3/es not_active Expired - Lifetime
- 1995-03-06 AT AT95914690T patent/ATE269102T1/de active
- 1995-03-06 AU AU21576/95A patent/AU685619B2/en not_active Ceased
- 1995-03-06 EP EP95914690A patent/EP0881908B1/en not_active Expired - Lifetime
- 1995-03-06 PT PT95914690T patent/PT881908E/pt unknown
- 1995-03-06 JP JP7523599A patent/JPH09510209A/ja active Pending
- 1995-03-06 CA CA002184916A patent/CA2184916C/en not_active Expired - Fee Related
- 1995-03-06 WO PCT/US1995/002847 patent/WO1995024211A1/en active IP Right Grant
- 1995-06-02 US US08/458,634 patent/US5614496A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU685619B2 (en) | 1998-01-22 |
DE69533176T2 (de) | 2005-09-15 |
WO1995024211A1 (en) | 1995-09-14 |
EP0881908A4 (en) | 2000-11-02 |
AU2157695A (en) | 1995-09-25 |
US5614496A (en) | 1997-03-25 |
PT881908E (pt) | 2004-11-30 |
ATE269102T1 (de) | 2004-07-15 |
CA2184916C (en) | 2008-05-13 |
EP0881908A1 (en) | 1998-12-09 |
CA2184916A1 (en) | 1995-09-14 |
JPH09510209A (ja) | 1997-10-14 |
ES2225840T3 (es) | 2005-03-16 |
DE69533176D1 (de) | 2004-07-22 |
EP0881908B1 (en) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0881908T3 (da) | Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst | |
EP0830138A4 (en) | USE OF FIBROBLAST GROWTH FACTORS TO STIMULATE BONE GROWTH | |
NO924697D0 (no) | Kirurgisk implantat og en fremgangsmaate for behandling avkirurgisk implantat | |
BR9900775A (pt) | Tratamento de desordens do esqueleto. | |
ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
SE8903529D0 (sv) | Medical use | |
PT762883E (pt) | Piridilbisfosfonatos utilizaveis como agentes terapeuticos | |
NO980375L (no) | Humant MP52 Arg protein | |
DE69133074D1 (de) | Einen basischen Fibroblastwachstumsfaktor enthaltende Mittel zur Behandlung von Knochenkrankheiten | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
KR950703993A (ko) | 치주 조직 질환 치료제(periodonal disease remedy) | |
FI970715A (fi) | Menetelmä luun parantamiseksi ja murtuman korjaamiseksi | |
Pedersen et al. | Subperiosteal transmucosal porous ceramic/titanium implants: Clinical experience from three cases | |
SU1064938A1 (ru) | Способ лечени переломов проксимального конца плечевой кости | |
SU1438725A1 (ru) | Способ лечени ложных суставов | |
IT8323597A0 (it) | Impianto endoosseo per il fissaggio di denti artificiali nell'osso mascellare. | |
RU1804797C (ru) | Способ эндоссальной имплантации | |
SU1192799A1 (ru) | Способ пластики крыши вертлужной впадины | |
Friedlander et al. | Selective resection of the circumoral musculature for enhancement of mandibular denture stability | |
UA33571A (uk) | Спосіб лікування травматичного перелому нижньої щелепи | |
TW224943B (en) | The pharmaceutical composition for the stimulation of bone formation | |
Kentjono | Rekonstruksi mandibula pasca reseksi tumor di Laboratorium Telinga Hidung dan Tenggorok RSU Dr. Soetomo Surabaya 1987-2003 | |
Held et al. | The investigation period 1965–1970 | |
UA23896A (uk) | Спосіб лікування зламів нижньої щелепи із сповільненою консолідацією | |
UA30310A (uk) | Спосіб лікування механічної жовтяниці у експериментальних тварин |